Literature DB >> 7480575

Cognitive performance in patients recovering from depression.

S Kuny1, H H Stassen.   

Abstract

Investigations into the development of cognitive impairment in 30 hospitalized depressive patients have suggested that such disturbances encompass two dichotomous entities: a core entity of long-persisting, therapy-resistant impairment and an entity of reversible impairment with a prompt onset of improvement. The course of improvement turned out to evolve largely independently with respect to psychopathology: about one half of patients displayed severe cognitive dysfunctions which remained virtually unchanged until hospital discharge, while 80% significantly improved within the first 12 days with respect to their depressive symptoms, and 53.3% displayed a clear response to treatment at the time of hospital discharge. In particular, a considerable number of patients with a significant reduction of depressive symptomatology at hospital discharge still suffered from severe cognitive dysfunctions. Neither antidepressant or antipsychotic medication nor acute side effects due to medication explained the development of cognitive impairment. Accordingly, cognitive impairment seems to represent an essentially independent syndrome complex comparable to 'deficits' or 'negative symptoms' in schizophrenia. On the other hand, single case correlation analysis revealed a somewhat closer relationship of cognitive impairment with speech behavior and voice sound characteristics. Two thirds of patients displayed significant correlations between cognitive performance scores and second-order constructs like speech flow, dynamics or intonation. However, the respective subgroups defined by significant correlations with single speech parameters were relatively small (< or = 35% of cases), thus indicating that there exist large interindividual differences as to how cognitive impairment affects the patients' speech.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7480575     DOI: 10.1159/000284922

Source DB:  PubMed          Journal:  Psychopathology        ISSN: 0254-4962            Impact factor:   1.944


  7 in total

1.  Executive function improvement upon remission of recurrent unipolar depression.

Authors:  Eva Biringer; Astri Lundervold; Kirsten Stordal; Arnstein Mykletun; Jens Egeland; Ronald Bottlender; Anders Lund
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2005-04-01       Impact factor: 5.270

2.  Psychiatric illness and subsequent traumatic brain injury: a case control study.

Authors:  J R Fann; A Leonetti; K Jaffe; W J Katon; P Cummings; R S Thompson
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-05       Impact factor: 10.154

3.  Depression screening using the Patient Health Questionnaire-9 administered on a touch screen computer.

Authors:  Jesse R Fann; Donna L Berry; Seth Wolpin; Mary Austin-Seymour; Nigel Bush; Barbara Halpenny; William B Lober; Ruth McCorkle
Journal:  Psychooncology       Date:  2009-01       Impact factor: 3.894

4.  Telephone and in-person cognitive behavioral therapy for major depression after traumatic brain injury: a randomized controlled trial.

Authors:  Jesse R Fann; Charles H Bombardier; Steven Vannoy; Joshua Dyer; Evette Ludman; Sureyya Dikmen; Kenneth Marshall; Jason Barber; Nancy Temkin
Journal:  J Neurotrauma       Date:  2015-01-01       Impact factor: 5.269

5.  Response time variability and response inhibition predict affective problems in adolescent girls, not in boys: the TRAILS study.

Authors:  Patricia A M van Deurzen; Jan K Buitelaar; J Agnes Brunnekreef; Johan Ormel; Ruud B Minderaa; Catharina A Hartman; Anja C Huizink; Anne E M Speckens; A J Oldehinkel; Dorine I E Slaats-Willemse
Journal:  Eur Child Adolesc Psychiatry       Date:  2012-02-22       Impact factor: 4.785

6.  Task- and Treatment Length-Dependent Effects of Vortioxetine on Scopolamine-Induced Cognitive Dysfunction and Hippocampal Extracellular Acetylcholine in Rats.

Authors:  Alan L Pehrson; Todd M Hillhouse; Nasser Haddjeri; Renaud Rovera; Joseph H Porter; Arne Mørk; Gennady Smagin; Dekun Song; David Budac; Manuel Cajina; Connie Sanchez
Journal:  J Pharmacol Exp Ther       Date:  2016-07-11       Impact factor: 4.030

7.  Migraine and traumatic brain injury: a cohort study in Taiwan.

Authors:  Qing-Rui Wang; Ying-Yi Lu; Ying-Ju Su; Hao Qin; Li Zhang; Ming-Kung Wu; Cong-Liang Zhang; Chieh-Hsin Wu
Journal:  BMJ Open       Date:  2019-07-30       Impact factor: 2.692

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.